Epigenetic Defects in the B cell lineage of Systemic Lupus Erythematosus Patients Display Population-Specific Patterns.
Determine the stage in B cell development that a Systemic Lupus Erythematosus (SLE)-associated DNA methylation signature originates in African American (AA) and European American (EA) individuals and assess its ability to predict SLE status in individual and mixed immune cells. B cells from AA (n = 31) and EA (n = 49) patients were sorted using fluorescence activated cell sorting (FACS) into five subsets. DNA methylation measured at ~460,000 CpG sites was interrogated in each subset. Enrichment analysis of transcription factor interaction at SLE-associated methylation sites was performed. A random forest algorithm identified an epigenetic signature of SLE in the B cell subsets, which validated in an independent cohort. Regression analysis across all B cell stages resulted in 60 CpGs that reached genome-wide significance (p ≤ 1.07x10-7 ). Interrogation of ethnicity-specific CpGs associated with SLE revealed a hypomethylated pattern enriched for interferon-regulated genes and EBF1 binding (p < 0.001) in AA patients. Predictive models developed in the transitional B cell subset distinguished AA SLE patients from controls when applied to other B cell subsets (mean ROC-AUC = 0.98), as well as CD19+ pan-B cells (ROC-AUC = 0.95) and CD4+ pan-T cells (ROC-AUC = 0.97) from an independent cohort. Our results indicate that SLE-specific methylation patterns are ethnicity dependent. Epigenetic changes near interferon-regulated genes early in B cell development is a hallmark of SLE in AA females. EBF1 binding sites are highly enriched for significant methylation changes, nominating it as a potential regulator of SLE-associated epigenetic changes. This article is protected by copyright. All rights reserved.